Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
9.388
Zitationen
28
Autoren
2015
Jahr
Abstract
Among patients with advanced nonsquamous NSCLC that had progressed during or after platinum-based chemotherapy, overall survival was longer with nivolumab than with docetaxel. (Funded by Bristol-Myers Squibb; CheckMate 057 ClinicalTrials.gov number, NCT01673867.).
Ähnliche Arbeiten
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 · 30.895 Zit.
AJCC Cancer Staging Manual
2016 · 17.402 Zit.
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 · 15.274 Zit.
The blockade of immune checkpoints in cancer immunotherapy
2012 · 13.542 Zit.
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
2012 · 12.520 Zit.
Autoren
- H. Borghaei
- L. Paz-Ares
- Leora Horn
- David R. Spigel
- Martin Steins
- Neal Ready
- Laura Q.M. Chow
- Everett E. Vokes
- Enriqueta Felip
- Esther Holgado
- Fabrice Barlési
- M. Kohlhufl
- Óscar Arrieta
- M. Burgio
- Jérôme Fayette
- H. Lena
- Elena Poddubskaya
- David E. Gerber
- Scott Gettinger
- Charles M. Rudin
- Naiyer A. Rizvi
- L. Crina
- George R. Blumenschein
- Scott Antonia
- Cécile Dorange
- Christopher Harbison
- F. Graf Finckenstein
- Julie R. Brahmer
Institutionen
- University Hospital Heidelberg(DE)
- Heidelberg University(DE)
- Hebron University(PS)
- Fox Chase Cancer Center(US)
- Centre Hospitalier Universitaire de Rennes(FR)
- Hospital Universitario Virgen del Rocío(ES)
- Breast Cancer Research Foundation(US)
- Vanderbilt-Ingram Cancer Center
- Sarah Cannon(US)
- Tennessee Oncology(US)
- Duke Medical Center(US)
- Seattle University(US)
- University of Washington(US)
- University of Chicago(US)
- Vall d'Hebron Institute of Oncology
- Hospital Universitario HM Sanchinarro(ES)
- Aix-Marseille Université(FR)
- Assistance Publique Hôpitaux de Marseille(FR)
- Robert Bosch Hospital(DE)
- Instituto Nacional de Cancerología(MX)
- Istituti di Ricovero e Cura a Carattere Scientifico(IT)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)
- Centre Léon Bérard(FR)
- Russian Cancer Research Center NN Blokhin(RU)
- The University of Texas Southwestern Medical Center(US)
- Yale Cancer Center(US)
- Memorial Sloan Kettering Cancer Center(US)
- Azienda Ospedaliera di Perugia(IT)
- Moffitt Cancer Center(US)
- Bristol-Myers Squibb (United States)(US)
- Sidney Kimmel Comprehensive Cancer Center(US)